These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20465392)

  • 41. Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.
    Grimaldi C; Capasso A
    Mini Rev Med Chem; 2012 Oct; 12(11):1119-26. PubMed ID: 22625418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs.
    Mollinedo F
    IDrugs; 2005 Feb; 8(2):127-43. PubMed ID: 15696415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploration of the functional proteome: lessons from lipid rafts.
    Shaw AR; Li L
    Curr Opin Mol Ther; 2003 Jun; 5(3):294-301. PubMed ID: 12870440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid rafts: a nexus for endocannabinoid signaling?
    McFarland MJ; Barker EL
    Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential dependence of the ingestion of necrotic cells and TNF-alpha / IL-1beta production by murine macrophages on lipid rafts.
    Acosta-Pérez G; Maximina Bertha Moreno-Altamirano M; Rodríguez-Luna G; Javier Sánchez-Garcia F
    Scand J Immunol; 2008 Oct; 68(4):423-9. PubMed ID: 18782272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of death receptors--relevance in cancer therapies.
    de Thonel A; Eriksson JE
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):123-32. PubMed ID: 16126242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
    Quest AF; Leyton L; Párraga M
    Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
    Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts.
    Kusumi A; Koyama-Honda I; Suzuki K
    Traffic; 2004 Apr; 5(4):213-30. PubMed ID: 15030563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cholesterol and lipid rafts in the biological membranes. Role in the release, reception and ion channel functions].
    Petrov AM; Zefirov AL
    Usp Fiziol Nauk; 2013; 44(1):17-38. PubMed ID: 23662472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
    Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
    Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.
    Márquez DC; Chen HW; Curran EM; Welshons WV; Pietras RJ
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):91-100. PubMed ID: 16388889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid rafts as a therapeutic target.
    Sviridov D; Mukhamedova N; Miller YI
    J Lipid Res; 2020 May; 61(5):687-695. PubMed ID: 32205411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redistribution of CD95 into the lipid rafts to treat cancer cells?
    Segui B; Legembre P
    Recent Pat Anticancer Drug Discov; 2010 Jan; 5(1):22-8. PubMed ID: 19663773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signaling pathways from membrane lipid rafts to JNK1 activation in reactive nitrogen species-induced non-apoptotic cell death.
    Wu YT; Zhang S; Kim YS; Tan HL; Whiteman M; Ong CN; Liu ZG; Ichijo H; Shen HM
    Cell Death Differ; 2008 Feb; 15(2):386-97. PubMed ID: 18007661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism.
    Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F
    Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current view on the mechanism of action of perifosine in cancer.
    Fensterle J; Aicher B; Seipelt I; Teifel M; Engel J
    Anticancer Agents Med Chem; 2014 May; 14(4):629-35. PubMed ID: 24628236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
    Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
    Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.